Merck Jumps On Neurostim Technology, Signing Agreements With Start-Ups
The biotech giant signed a commercial agreement with bioelectronics company Innervia, and the two will work collaboratively on vagus nerve stimulating technologies.
You may also be interested in...
By utilizing the properties of graphene, INBRAIN hopes to develop improved electrodes implanted in the brain, raising the potential of neuromodulation for treating complex neurological disorders.
Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market
The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.
The company has developed a biosensor that provides information to health care professionals concerning the health of a patient’s wound.